Relevance of
ARID1A
SWI/SNF complex
endometrial cancer
molecular classification
next-generation sequencing
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
25 Feb 2022
25 Feb 2022
Historique:
received:
07
02
2022
accepted:
21
02
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
26
3
2022
Statut:
epublish
Résumé
Since the Cancer Genome Atlas (TCGA) project identified four distinct groups based on molecular alterations, mutation analyses have been integrated into the characterization of endometrial carcinomas (ECs). ARID1A seems to be the subunit more involved in the loss of function of the SWI/SNF complex in ECs. The aim of this study is to define the relevance of
Identifiants
pubmed: 35328145
pii: diagnostics12030592
doi: 10.3390/diagnostics12030592
pmc: PMC8947028
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Cassa di Risparmio in Bologna
ID : 2020.0406
Références
Cancer. 2017 Mar 1;123(5):802-813
pubmed: 28061006
J Clin Pathol. 2022 Jul;75(7):488-492
pubmed: 33820865
Diagnostics (Basel). 2021 Jan 29;11(2):
pubmed: 33572888
Pharmacol Ther. 2018 Oct;190:15-23
pubmed: 29730444
Science. 2020 Feb 21;367(6480):875-881
pubmed: 32001526
Cell. 2020 Feb 20;180(4):729-748.e26
pubmed: 32059776
Diagnostics (Basel). 2021 Apr 14;11(4):
pubmed: 33919741
Diagnostics (Basel). 2020 Apr 23;10(4):
pubmed: 32340363
Structure. 2018 Jun 5;26(6):894-904.e2
pubmed: 29657133
Br J Cancer. 2015 Jul 14;113(2):299-310
pubmed: 26172027
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Hum Pathol. 2013 Jan;44(1):103-9
pubmed: 22939958
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Int J Cancer. 2022 Apr 1;150(7):1077-1090
pubmed: 34706070
Genome Biol. 2014;15(12):550
pubmed: 25516281
Front Oncol. 2021 Oct 29;11:757678
pubmed: 34804952
Oncogene. 2018 Aug;37(33):4611-4625
pubmed: 29760405
Oncol Rep. 2016 Feb;35(2):607-13
pubmed: 26572704
J Biol Chem. 2004 Apr 16;279(16):16670-6
pubmed: 14722072
Nat Biotechnol. 2015 Mar;33(3):290-5
pubmed: 25690850
J Pathol. 2011 Jul;224(3):328-33
pubmed: 21590771
Oncotarget. 2015 Nov 17;6(36):39088-97
pubmed: 26384299
Cancers (Basel). 2021 Apr 07;13(8):
pubmed: 33917230
Sci Rep. 2018 Jul 25;8(1):11205
pubmed: 30046040
Lancet. 2018 Mar 17;391(10125):1023-1075
pubmed: 29395269
Clin Cancer Res. 2016 Aug 15;22(16):4215-24
pubmed: 27006490
Int J Clin Oncol. 2011 Oct;16(5):605-9
pubmed: 21243393
Front Oncol. 2021 Oct 04;11:745187
pubmed: 34671561
World J Gastroenterol. 2021 Jun 7;27(21):2710-2726
pubmed: 34135550
Cancer Discov. 2015 Jul;5(7):752-67
pubmed: 26069190
Mod Pathol. 2013 Nov;26(11):1525-35
pubmed: 23702729
Int J Mol Sci. 2020 Sep 29;21(19):
pubmed: 33003368
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Front Oncol. 2021 Aug 02;11:679334
pubmed: 34414106
Cancers (Basel). 2021 Feb 25;13(5):
pubmed: 33668727
Oncotarget. 2016 Aug 30;7(35):56933-56943
pubmed: 27486766
Am J Surg Pathol. 2011 May;35(5):625-32
pubmed: 21412130
Nature. 2013 May 2;497(7447):67-73
pubmed: 23636398
J Obstet Gynaecol Res. 2013 Apr;39(4):872-5
pubmed: 23167774
Cell. 2020 Oct 29;183(3):802-817.e24
pubmed: 33053319